SRCR (Scavenger Receptor Cystein Rich-Domain) (Geodia cydonium, SRCRB4D, group B (4 domains) S4D-SRCRB, SRCRB-S4D)

1238 EUR

100ug

GEN607839

IgM

N/A

5F10

SRCR

Monoclonal

Antibodies

Mouse (Mus musculus)

Mnoclonal antibodies

N/A; SRCRM2; N/A; N/A

N/A; SRCRM2; N/A; N/A

N/A; SRCRM2; N/A; N/A

Affinity Purified by Protein G affinity chromatography.

Supplied as a lyophilized powder in PBS, pH 7.2. Reconstitute in ddH2O.

SRCR domain, membrane form 2; SRCR domain, membrane form 2; N/A; N/A; N/A

ELISA (EL/EIA), Western Blot (WB), Immunoprecipitation (IP), Immunohistochemistry (IHC)

N/A; Due to limited knowledge and inability for testing each and every species, the reactivity of the antibody may extend to other species which are not listed hereby.

Recognizes SRCR (Geodia cydonium); Since it is not possible to test each and every species our knowledge on the corss reactivity of the antibodies is limited. This particular antibody might cross react with speacies outside of the listed ones.

Lyophilized powder Store the antibody at +4 degrees Celsius for short term storage.. Reconstitute to nominal volume by adding sterile 40-50% glycerol and For optimal long term storage, the antibody should be kept at -20 degrees Celsius. Reconstituted product is stable for 12 months the antibody should be stored at -20 degrees Celsius.. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

The receptors are ligand binding factors of type 1, 2 or 3 and protein-molecules that receive chemical-signals from outside a cell. When such chemical-signals couple or bind to a receptor, they cause some form of cellular/tissue-response, e.g. a change in the electrical-activity of a cell. In this sense, am olfactory receptor is a protein-molecule that recognizes and responds to endogenous-chemical signals, chemokinesor cytokines e.g. an acetylcholine-receptor recognizes and responds to its endogenous-ligand, acetylcholine. However, sometimes in pharmacology, the term is also used to include other proteins that are drug-targets, such as enzymes, transporters and ion-channels.